Abbott has initiated a ABSORB III clinical trial of its drug eluting bioresorbable vascular scaffold (BVS) device, designed for the treatment of coronary artery disease patients. The Absorb device, which includes a multi-link stent ...
Tags: Abbott, ABSORB III clinical trial, drug eluting BVS, treatment